Skip to main content
. 2000 Jul;50(1):77–80. doi: 10.1046/j.1365-2125.2000.00230.x

Table 1.

Genotype frequencies among patients showing terodiline cardiotoxicity compared with published control frequencies.

Polymorphism and genotype Terodiline cardiotoxicity Control population
CYP2D6
(n = 8) (n = 662)*
Wt/wt 6 (0.75) 364 (0.55)
Mut/wt 1 (0.125) 267 (0.40)
Mut/Mut 1 (0.125) 31 (0.047)
CYP2C19
(n = 8) (n = 105)
Wt/wt 3 (0.375) 79 (0.75)
Mut/wt 4 (0.50) 24 (0.23)
Mut/mut 1 (0.125) 2 (0.02)
*

[12, Reference 13.